Trial intelligence / Profile preview

Progesterone as an ovulation trigger in IUI and IVF cycles

IRCT20240506061667N1Phase 3Completed

Sponsor
ACECR
Start
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of progesterone in infertility (2 cohorts), sponsored by ACECR. Primary endpoint: LH surge occurrence. Started Jun 2024; status: completed.

02

Drugs

progesterone
03

Conditions

infertility

Beyond the preview

Go deeper on IRCT20240506061667N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240506061667N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call